Table 2 Meta-analysis of clinical features of MGRS
From: Systematic review and meta-analysis of the clinical features of MGRS
Clinical Features | Studies | Effects model | OR/WMD | 95%CI | P-value | Heterogeneity | |
|---|---|---|---|---|---|---|---|
I2 | P-value | ||||||
Age(year) | 4 | Fixed | 1.78 | 0.21–3.35 | 0.026 | 1.8 | 0.383 |
Sex(%) | 4 | Random | 0.81 | 0.47–1.40 | 0.449 | 56.6 | 0.075 |
Hypertension(%) | 2 | Fixed | 0.54 | 0.4–0.73 | <0.001 | 0.0 | 0.571 |
Diabetes(%) | 3 | Fixed | 0.42 | 0.29–0.59 | <0.001 | 0.0 | 0.669 |
Albumin(g/dl) | 3 | Fixed | -0.26 | -0.38–0.14 | <0.001 | 0.0 | 0.450 |
Hemoglobin(g/dl) | 3 | Random | -0.26 | -1.12-0.60 | 0.554 | 72.4 | 0.027 |
Serum creatinine(mg/dl) | 4 | Fixed | 0.08 | -0.07-0.22 | 0.293 | 0.0 | 0.558 |
eGFR(ml/min/1.73 m2) | 3 | Fixed | -5.63 | -11.41-0.16 | 0.056 | 0.0 | 0.869 |
complement C3(mg/dl) | 2 | Random | -14.43 | -35.96-7.10 | 0.189 | 92.6 | <0.001 |
low complement C3 ratio(%) | 2 | Random | 2.93 | 0.52–16.46 | 0.222 | 64.9 | 0.091 |
complement C4(mg/dl) | 2 | Random | -2.68 | -7.68-2.32 | 0.293 | 73.0 | 0.054 |
urinary protein level(g/d) | 4 | Fixed | 0.76 | 0.31–1.20 | 0.001 | 42.0 | 0.160 |
urinary protein ≥ 1.5 g/d(%) | 3 | Fixed | 1.98 | 1.46–2.68 | <0.001 | 7.0 | 0.341 |
hematuria(%) | 4 | Random | 0.86 | 0.36–2.06 | 0.733 | 84.8 | <0.001 |
k-chain value(mg/l) | 2 | Random | 23.84 | -46.98-94.67 | 0.509 | 96.0 | <0.001 |
λ-chain value(mg/l) | 2 | Fixed | 29.02 | 16.55–41.49 | <0.001 | 0.0 | 0.593 |
abnormal free light chain ratio(%) | 3 | Random | 4.16 | 1.65–10.47 | 0.002 | 77.1 | 0.013 |
bone marrow puncture rate(%) | 3 | Random | 5.11 | 1.31–19.95 | 0.019 | 89.8 | <0.001 |
abnormal bone marrow outcome rate(%) | 2 | Random | 9.63 | 1.98–46.88 | 0.005 | 90.5 | 0.001 |